Borje Ljungberg

Professor, past chairman

Umeå Universitet Medicinska fakulteten

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Borje Ljungberg is a Professor at Umeå universitet Medicinska fakulteten in Sweden. His research interests include predictive tools for postoperative complications, healthcare costs related to preoperative renal biopsy, and the diagnostic accuracy of renal tumor biopsies. He has contributed significantly to the understanding of renal cell carcinoma treatment and personalized approaches in oncology through his recent articles.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Karin Strigård

Senior lecturer

Umeå Universitet Medicinska fakulteten

SWEDEN

View details

Per-Olof Lundgren

Karolinska Institutet

SWEDEN

View details

Leila Lujan-Barroso

Associate professor

University of Barcelona

SPAIN

View details

Magnus Hultin

Senior lecturer

Umea University

SWEDEN

View details

Abbas Chabok

Professor

SWEDEN

View details

Marthe De Boevre

Ghent University

BELGIUM

View details

Andreas Karlsson Rosenblad

Karolinska Institutet

SWEDEN

View details

Pernilla Sundqvist

School of Medicine, Örebro University

SWEDEN

View details

Jiri Zavadil

Deputy Branch Head

International Agency for Research on Cancer

FRANCE

View details

Sarah De Saeger

Professor

Ghent University

BELGIUM

View details

Anke Wesselius

NETHERLANDS

View details

Johan Hultdin

Umea University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Borje Ljungberg

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Healthcare costs in relation to increased use of preoperative renal tumour biopsies

Addressing the need for predictive tools in postoperative abdominal wall complications after nephrectomy – Evaluation of a novel abdominal bulge grading system using computed tomography

Reply to the letter to the editor about “recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Lundgren and Radros

Diagnostic accuracy and safety of renal tumour biopsy in patients with small renal masses and its impact on treatment decisions

Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis

Expression of HIF-α and their association with clinicopathological parameters in clinical renal cell carcinoma

Reply to Letter to the Editor about “Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Qiang et al

Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma – results from the National Swedish Kidney Cancer Register

Dietary vitamin D intake and the bladder cancer risk: A pooled analysis of prospective cohort studies

Spinal anaesthesia with clonidine: pain relief and earlier mobilisation after open nephrectomy - a randomised clinical trial.

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort

Kidney tumor biopsy – an unmet need for personalized treatment

Inflammatory response markers and survival prediction in patients with renal cell carcinoma

A psychometric evaluation of the Functional assessment of cancer therapy—kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure

Radical Nephrectomy: The Widening Gap Between Evolution of Technique and Evidence

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden

Collaborators (12)

Karin Strigård

Per-Olof Lundgren

Leila Lujan-Barroso

Magnus Hultin

Abbas Chabok

Marthe De Boevre

Andreas Karlsson Rosenblad

Pernilla Sundqvist

Jiri Zavadil

Sarah De Saeger

Anke Wesselius

Johan Hultdin

Make your next move.